Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Survodutide by Boehringer Ingelheim International for Renal Failure: Likelihood of Approval
Survodutide is under clinical development by Boehringer Ingelheim International and currently in Phase I for Renal Failure. According to GlobalData,...
Survodutide by Boehringer Ingelheim International for Liver Fibrosis: Likelihood of Approval
Survodutide is under clinical development by Boehringer Ingelheim International and currently in Phase II for Liver Fibrosis. According to GlobalData,...
Survodutide by Boehringer Ingelheim International for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
Survodutide is under clinical development by Boehringer Ingelheim International and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According...
Survodutide by Boehringer Ingelheim International for Obesity: Likelihood of Approval
Survodutide is under clinical development by Boehringer Ingelheim International and currently in Phase III for Obesity. According to GlobalData, Phase...